Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.0K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.0K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

213
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
213
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

134
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
134
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

993
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
993
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

150
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
150
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.

Antimicrobial agents and chemotherapy·2026
Same author

PKPD-Based Translational Modeling of Calaspargase Pegol Preclinical Activity in Hepatocellular Carcinoma.

European journal of drug metabolism and pharmacokinetics·2026
Same author

Meropenem and fosfomycin against Klebsiella pneumoniae: author's response.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Prospective study of pharmacokinetics of isavuconazole in critically ill patients undergoing continuous hemodialysis with and without acute-on-chronic liver failure.

Annals of intensive care·2026
Same author

Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial.

Nature medicine·2026
Same author

Transplantation of human stem cell-derived cone photoreceptors partially restores vision in aged rd1 mice with advanced retinal degeneration.

Stem cells (Dayton, Ohio)·2026

Related Experiment Video

Updated: Aug 29, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

Drug Combination Modeling: Methods and Applications in Drug Development.

Rachael A Pearson1, Sebastian G Wicha2, Malek Okour3

  • 1Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.

Journal of Clinical Pharmacology
|September 11, 2022
PubMed
Summary
This summary is machine-generated.

Combination therapies offer improved efficacy and reduced toxicity for complex diseases. This review details mathematical modeling methods to evaluate drug interactions for clinical trial development and simulation.

Keywords:
clinical trial simulationcombination modelingdrug antagonismdrug interactionsdrug synergydrug therapy

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Related Experiment Videos

Last Updated: Aug 29, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Area of Science:

  • Pharmacology
  • Clinical Pharmacology
  • Biomathematics

Background:

  • Combination therapies are increasingly vital for treating complex diseases, offering enhanced efficacy and reduced toxicity.
  • Evaluating drug interactions in combination therapy is crucial for drug development.
  • Mathematical modeling is essential for quantifying pharmacokinetic and pharmacodynamic interactions.

Purpose of the Study:

  • To review methods for evaluating combination drug interactions in clinical trial development.
  • To provide practical guidelines for using combination modeling in clinical trials.
  • To address challenges in selecting and applying mathematical models for drug combination studies.

Main Methods:

  • Literature review of mathematical modeling techniques for drug interaction analysis.
  • Exploration of pharmacokinetic/pharmacodynamic (PK/PD) modeling approaches.
  • Discussion of model application in clinical trial simulation.

Main Results:

  • Overview of various mathematical models used to quantify drug interactions.
  • Identification of challenges in model selection and application.
  • Guidance on utilizing modeling for predicting combination therapy effects.

Conclusions:

  • Mathematical modeling provides a framework for evaluating combination drug therapies.
  • Effective use of modeling can aid in the design and simulation of clinical trials.
  • This review offers practical insights for researchers and developers in combination therapy.